IPSEF - Ipsen Highly Undervalued In This Price Range Due To Palovarotene Hold
Editor's note: Seeking Alpha is proud to welcome Michal Kalisiak as a new contributor. It's easy to become a Seeking Alpha contributor and earn money for your best investment ideas. Active contributors also get free access to SA PREMIUM. Click here to find out more »
Company
Ipsen (Euronext: IPN; ADR: [[IPSEY]] [[IPSEF]]) is a €7.045 billion market cap french biopharmaceutical company that specializes in the research, development, manufacturing and marketing of medications. The drugmaker's sales are distributed all over the world (over 115 countries) with Europe on top – 53.9% of sales. Sales are